Yukiya Suzuki
Gifu Pharmaceutical University(JP)Pharmaceuticals and Medical Devices Agency(JP)
Publications by Year
Research Areas
Acute Ischemic Stroke Management, Neuroinflammation and Neurodegeneration Mechanisms, Neurological Disease Mechanisms and Treatments, Protease and Inhibitor Mechanisms, Amyotrophic Lateral Sclerosis Research
Most-Cited Works
- → The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment(2013)134 cited
- → Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke(2013)99 cited
- → Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia(2012)90 cited
- → The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model(2012)72 cited
- → Diabetes Mellitus Aggravates Hemorrhagic Transformation after Ischemic Stroke via Mitochondrial Defects Leading to Endothelial Apoptosis(2014)66 cited
- → Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database(2015)64 cited
- → Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia–reperfusion injury(2014)62 cited
- → A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice(2012)61 cited
- → A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator(2012)58 cited
- → Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age(2015)24 cited